Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex Tablet 80 mg.

Trial Profile

Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex Tablet 80 mg.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Jan 2013

At a glance

  • Drugs Bicalutamide (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions
  • Acronyms CAMON
  • Sponsors AstraZeneca
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 09 Dec 2010 Planned end date changed from 1 Apr 2012 to 1 Mar 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top